In a 28-year-old woman with acute brucellosis presenting with fever, malaise, arthralgia, back pain, hepatosplenomegaly, anemia, thrombocytopenia, and blood cultures growing gram‑negative coccobacilli after raw‑milk ingestion, what is the optimal duration of antimicrobial therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Optimal Duration of Therapy for Acute Brucellosis

The optimal duration of antimicrobial therapy for this patient with acute uncomplicated brucellosis is 6 weeks (Answer B). 1, 2

Treatment Duration Rationale

Standard treatment for uncomplicated brucellosis requires a 6-week regimen of doxycycline (100 mg twice daily) combined with either streptomycin (1 g daily) for 2-3 weeks or rifampicin (600-900 mg daily) for the full 6 weeks. 1, 2 This duration has been established by the World Health Organization and represents the evidence-based standard for achieving cure while minimizing relapse risk. 1

Clinical Context Supporting 6-Week Duration

This patient presents with classic acute brucellosis features:

  • Fever, malaise, arthralgia, and back pain are characteristic presenting symptoms 2, 3
  • Hepatosplenomegaly is present in 31-55% of pediatric and adult cases 3
  • Raw milk ingestion is the primary transmission route 4, 3
  • Gram-negative coccobacilli on blood culture confirms the diagnosis 2
  • Mild anemia and thrombocytopenia are common non-specific findings in 64-65% of cases 3, 5

Importantly, there is no evidence of complicated disease (no spondylitis mentioned despite back pain, no neurobrucellosis, no endocarditis), which would require longer treatment duration. 2

Why Not Other Durations?

  • 3 weeks (Option A): Too short and associated with significantly higher relapse rates, particularly when single-drug therapy or inadequate duration is used 3
  • 12 weeks (Option C): Reserved for complicated cases such as neurobrucellosis, endocarditis, or spondylitis requiring extended therapy 2, 5
  • 24 weeks (Option D): This represents the surveillance period for exposed individuals, not the treatment duration for active disease 6

Expected Outcomes with 6-Week Treatment

  • Relapse rates of 5-15% are expected even with appropriate 6-week treatment 1, 2
  • Clinical improvement should occur within 7-14 days, with fever typically resolving in 3-4 days 2, 3
  • Relapses are usually mild and respond to the same treatment regimens 1, 2
  • Cure rates exceed 90% when combination therapy is used for the full 6-week duration 4, 7

Critical Treatment Considerations

The specific antibiotic combination matters as much as duration: Doxycycline plus streptomycin has the lowest relapse rate, while doxycycline plus rifampicin is equally effective and more practical given streptomycin's limited availability. 1 Single-drug therapy or shorter courses are associated with relapse rates approaching 50%. 7

References

Guideline

Brucellosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Brucellosis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Osteoarticular brucellosis in children.

Annals of the rheumatic diseases, 1990

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Human brucellosis in Kuwait: a prospective study of 400 cases.

The Quarterly journal of medicine, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.